2021
DOI: 10.1186/s43168-021-00062-1
|View full text |Cite
|
Sign up to set email alerts
|

Prognostic biomarkers in predicting mortality in respiratory patients with ventilator-associated pneumonia

Abstract: Background Ventilator-associated pneumonia (VAP) is the most common nosocomial infection. Red cell distribution width (RDW) and neutrophil-lymphocyte ratio (NLR) are prognostic factors to mortality in different diseases. The aim of this study is to evaluate prognostic efficiency RDW, NLR, and the Sequential Organ Failure Assessment (SOFA) score for mortality prediction in respiratory patients with VAP. Results One hundred thirty-six patients mechan… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
1
0
1

Year Published

2021
2021
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 72 publications
0
1
0
1
Order By: Relevance
“…This study included all bloodstream infections and did not specifically assess healthcare-associated infections. Other studies examining ventilator-associated pneumonia have found disease severity, comorbidities, and pneumonia severity as risk factors for mortality (14,15). Serum albumin levels and organ infections are linked to death in older adult patients with surgical site infections (16).…”
Section: Introductionmentioning
confidence: 99%
“…This study included all bloodstream infections and did not specifically assess healthcare-associated infections. Other studies examining ventilator-associated pneumonia have found disease severity, comorbidities, and pneumonia severity as risk factors for mortality (14,15). Serum albumin levels and organ infections are linked to death in older adult patients with surgical site infections (16).…”
Section: Introductionmentioning
confidence: 99%
“…El impacto biológico de las enfermedades graves con variabilidad del ADE continúa en estudio, especialmente en el contexto de sepsis grave y shock séptico, donde las mediciones seriadas del ADE podrían utilizarse como factor pronóstico [20][21][22][23][24]. Así mismo, se viene investigando en COVID-19, donde podría utilizarse como un biomarcador simple y confiable para predecir la gravedad y clasificar el riesgo [25][26][27][28][29][30], y en pacientes con neumonía asociada a ventilador, donde junto al índice neutrófilo-linfocito ha demostrado correlación con mortalidad [31].…”
Section: Introductionunclassified